Sofosbuvir with velpatasvir in treatment-naive noncirrhotic patients with genotype 1 to 6 hepatitis C virus infection: a randomized trial

GT Everson, WJ Towner, MN Davis… - Annals of internal …, 2015 - acpjournals.org
This article has been corrected. The original version (PDF) is appended to this article as a
Supplement. Background: Effective, pangenotypic treatments for hepatitis C virus (HCV) …
被引用次数：146 相关文章
[PDF] natap.org

[PDF][PDF] Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection

GT Everson, WJ Towner, MN Davis, DL Wyles… - 2015 - natap.org
Background: Effective, pangenotypic treatments for hepatitis C virus (HCV) infection are
needed. Objective: To assess the safety and efficacy of sofosbuvir with velpatasvir in …

Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial.

GT Everson, WJ Towner, MN Davis… - Annals of Internal …, 2015 - europepmc.org
Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6
Hepatitis C Virus Infection: A Randomized Trial. - Abstract - Europe PMC Sign in | Create an …
[PDF] natap.org

[PDF][PDF] Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection

GT Everson, WJ Towner, MN Davis, DL Wyles… - 2015 - natap.org
Background: Effective, pangenotypic treatments for hepatitis C virus (HCV) infection are
needed. Objective: To assess the safety and efficacy of sofosbuvir with velpatasvir in …

Sofosbuvir with velpatasvir in treatment-naive noncirrhotic patients with genotype 1 to 6 hepatitis C virus infection: a randomized trial.

GT Everson, WJ Towner, MN Davis, DL Wyles… - 2015 - cabidigitallibrary.org
Background: Effective, pangenotypic treatments for hepatitis C virus (HCV) infection are
needed. Objective: To assess the safety and efficacy of sofosbuvir with velpatasvir in …

Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial

GT Everson, WJ Towner, MN Davis, DL Wyles… - 2015 - pubmed.ncbi.nlm.nih.gov
Background Effective, pangenotypic treatments for hepatitis C virus (HCV) infection are
needed. Objective To assess the safety and efficacy of sofosbuvir with velpatasvir in patients …